In addition, as N-MYC is also overexpressed or amplified in medulloblastoma, retinoblastoma, and subsets of breast, prostate, and small-cell lung cancers [21], the work presented here may have implications for more than just high-risk neuroblastoma in general. The gene discussed is MYCN; the disease is medulloblastoma.